FAST Australia launched in October 2010. Inspired by the mission and energy of FAST in the United States we are driven to address the lack of research and understanding into Angelman syndrome in Australia. Our combined energies create a powerful force in the search for therapeutic interventions and a cure to treat Angelman syndrome.
The Foundation for Angelman Syndrome Therapeutics Australia (or FAST Australia) is an organisation of families and professionals dedicated to assisting individuals living with Angelman syndrome to realise their full potential and quality of life through funding research, education, and advocacy. Our focus is treatments that will improve the symptoms of Angelman syndrome and ultimately research that will provide a cure.
We are confident that our goals are now within reach and together, with your help, we will change lives.
Board of Directors
Our Board of Directors utilise their expertise in various fields to advance our mission, assess our strategies and create opportunities to aggressively pursue our goals.
Scientific Advisory Board
The Scientific Advisory Board (or SAB) consists of recognised clinicians and scientists considered experts in their respective fields. Specific disciplines represented by the SAB include: paediatric neurology, epilepsy, diet and nutrition, human neurodevelopment, human cognitive disorders, small animal behaviour, animal models of human disorders, mechanisms of learning and memory, synaptic plasticity and function, cellular signal transduction, cellular protein trafficking, epigenetics and genetics.
As an Australian business, and a Health Promotion Charity with DGR status we realise that transparency is vitally important to our members. FAST Australia was established in 2010.
We are registered with the Australian Charities and Not-for-Profits Commission (ACNC). Our listing, with up to date financials, can be found here.